Zobrazeno 1 - 10
of 75
pro vyhledávání: '"N A Bokhan"'
Publikováno v:
Терапевтический архив, Vol 84, Iss 10, Pp 51-55 (2012)
Aim. To evaluate the efficacy of Remaxol used to treat post-withdrawal disorders in alcoholic patients with comorbid liver damage. Subjects and methods. The authors assessed the severity of clinical parameters, such as pathological craving and anhedo
Externí odkaz:
https://doaj.org/article/d6cb778f6d0c40708e426c519fd7427b
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 14, Iss 3, Pp 32-37 (2022)
Alcohol dependence (AD) and mood disorders are not only a serious medical and socio-economic problem for modern society, but also the cause of social adaptation disorders that form even in the early stages of each of these disorders, as well as in ca
Externí odkaz:
https://doaj.org/article/e2d028a2e1694e6daf8f500d31d53157
Publikováno v:
European Psychiatry, Vol 66, Pp S876-S877 (2023)
Introduction Depression can be considered to be a common psychological response to adversity or loss from which an individual may recover quickly based on a natural resilience mechanism. In major depressive disorder, however, we see that biopsychosoc
Externí odkaz:
https://doaj.org/article/0fed693aa1e04bc081f6934795e3636d
Publikováno v:
Медицинская иммунология, Vol 23, Iss 4, Pp 871-880 (2021)
Exposure to alcohol causes imbalances in neuroimmune function and impaired brain development. Alcohol activates the innate immune signaling pathways in the brain. Neuroimmune molecules expressed and secreted by glial cells of the brain (microglia, ol
Externí odkaz:
https://doaj.org/article/4e36df49f7a542808fed87fefd6c2b52
Autor:
E. V. Mikhalitskaya, N. M. Vyalova, O. Yu. Fedorenko, O. V. Roshchina, G. G. Simutkin, N. A. Bokhan, S. A. Ivanova
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 3, Pp 48-52 (2021)
Alcohol dependence (AD) and affective disorders (ADs) are serious medical and socio-economic problems of modern society. It is hypothesized that both disorders share a common neurobiological basis. Phosphatidylinositol-4-phosphate-5-kinase type 2 alp
Externí odkaz:
https://doaj.org/article/ee407dba1f7f4499b261a49ec6cf8cfc
Autor:
S. A. Galkin, S. N. Vasilieva, G. G. Simutkin, G. D. Tkacheva, T. A. Oshkina, S. A. Ivanova, N. A. Bokhan
Publikováno v:
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, Vol 0, Iss 4, Pp 26-32 (2020)
The aim is to study the features of brain activity in patients with affective disorders, depending on the response to therapy. Material and methods. The study included 84 patients with affective disorder. All patients received syndrome-induced psycho
Externí odkaz:
https://doaj.org/article/af36a99979f14036badbc28a52363c7b
Publikováno v:
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, Vol 0, Iss 4-1, Pp 124-126 (2019)
One of the common pathogenetic mechanisms of the formation of alcohol dependence and depressive disorders can be a violation of the neurotransmitter systems, in particular — dopamine. Phosphatidylinositol-4-phosphate-5-kinase type 2 alpha (PIP5K2A)
Externí odkaz:
https://doaj.org/article/728ac527680949fc931e4bd39e0ed3d0
Publikováno v:
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, Vol 0, Iss 2, Pp 90-96 (2018)
Te paper reports on the features of alexithymic space structure in patients with cardiovascular diseases, comparison of the obtained results with the group of healthy respondents. Tis information is useful for health psychologists to develop models o
Externí odkaz:
https://doaj.org/article/e71ad52e05ca4de5bccec72fadefa6b8
Publikováno v:
Psikhiatriya. 21:43-51
Background: tobacco use is one of the leading risk factors for early death and disability worldwide. Comorbidity of anxiety disorders and nicotine dependence reduces the efficiency of the specialist complex therapy of tobacco dependence. Of significa
Autor:
I. G. Bakulin, N. A. Bokhan, P. O. Bogomolov, N. I. Geyvandova, M. V. Matsiyevich, M. A. Vinnikova, V. G. Morozov, O. M. Khromtsova, G. S. Soldatova, O. Yu. Shiryayev, R. D. Ilyuk, K. V. Rybakova, A. G. Katkovskaya, S. V. Teplykh, A. A. Bagretsova, M. V. Krasnova, Ye. V. Alekseyeva, A. V. Anipchenko, Ye. V. Baskakov
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 27, Iss 3, Pp 57-68 (2018)
Material and methods. The original study included overall 120 patients with ALD, who were randomized in two identical groups. The patients of the main group (group A) received 2 courses of therapy: the first - Phosphogliv 5 mg/day as intravenous bolu
Externí odkaz:
https://doaj.org/article/4f495eb6776240bda9501c18da8c6da0